Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities


Please find all related articles below.

Clinical Trials Directive: A barrier to research and innovation in Europe?

EPHA member - Cancer Research UK - presents its policy recommendations to reform the Clinical Trials Directive. A new policy briefing by Cancer Research UK, ’’Supporting research, protecting patients’’ has been launched during a meeting in the European Parliament. The briefing contains a number of key recommendations to reform the Clinical Trials Directive, amongst them: option of coordinated assessment procedure for multi-national clinical trials restriction (...)

Tobacco industry attempts to undermine Framework Convention on Tobacco using the German government

Researchers at the Tobacco Control Research Group have shown in a paper published in the British Medical Journal how the Tobacco Industry attempted to use the German government to undermine the WHO Framework Convention on Tobacco Control (FCTC). Germany has been identified as one of a few high-income countries that opposed a strong Framework Convention on Tobacco Control (FCTC). A group of researchers has examined the role that the tobacco industry played in influencing the German (...)

5th European Public Health Conference - call for abstracts

The 5th European Public Health Conference will take place in Malta in November 2012. The overall theme will focus on "All Inclusive Public Health". The call for abstracts opens on the 1st of February 2012. Information on submission and deadlines is available below. The 5th European Public Health Conference aims to offer a means for exchanging information and a platform for debate to researchers, policy makers, and practitioners in the field of public health and health services research. (...)

EPHA position on the European Research Area

EPHA answered the DG Research consultation on the European Research Area. In the EPHA response, the role of CSOs and the importance of health research are highlighted. In its position, EPHA highlights the following points: Research and innovation should address the most pressing societal challenges benefiting all members of society; Energy and climate change along with population ageing and health are some of our biggest societal challenges and must be addressed by the ERA to (...)

Horizon 2020: will broader innovation improve health and wellbeing?

€31.7 billion will be allocated to tackling the major issues affecting the lives of European citizens and €8.5 billion euros are earmarked to health.


EPHA explainer - EU funds to support NGOs

There are many ways in which the EU supports Non Governmental Organisations to operate in Europe. This article details what they are, who is elligible and how organisations can apply.


European Antibiotic Awareness Day 2011

On 17 November 2011 the European Commission will launch its Strategy on Antimicrobial Resistance (AMR) to coincide with this year’s European Antibiotic Awareness Day (EAAD). Antimicrobiral resistance represents a growing public health concern and the 2011 EAAD will be focused on one way of adressing the issue - national initiatives to promote the prudent use of antibiotics. An event is being held to mark the EEAD and the launch of the Commission’s Strategy on Antimicrobial (...)

“Horizon 2020: Investing in the common good” Treating knowledge as a public good in EU research and innovation

Health Action International, an EPHA member and the Transatlantic Consumer Dialogue, an EPHA partner are co-organising an event on the future Horizons 2020 research programme. MEP Luigi Berlinguer (S&D IT) & MEP Philippe Lamberts (Greens/EFA BE) are hosting: “Horizon 2020: Investing in the common good” Treating knowledge as a public good in EU research and innovation Horizon (...)

New EU Communication on ’Partnerships’ in Research: towards increasing public private partnerships?

The European Commission recently published a new Communication entitled ’Partnering in research and innovation’, which aims to highlights the importance of partnering in European Research and Innovation. The Commission intends to encourage public and private actors to collaborate at European level to apply research and innovation solutions to major challenges facing society has been issued by the European Commission. The Commission Communication Partnering in research and (...)
Also about: EU budget

EMA Patients’ and Consumers’ Working Party Meeting September 2011

On Tuesday 13 September the European Medicines Agency convened a meeting of its Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations (PCWP). The meeting addressed a number of different issues on the European Medicines’ Agency agenda which affect patients’ and consumers’ organisations. The meeting covered 3 areas of the agencies work: 1. Pharmacovigilance legislation A presentation was given on how patient reporting can (...)